Catalog record · Data & Analytics
Stage as of source date not established · historical report, not live reconfirmation.
Amgen trial-site selection and recruitment forecasting
Primary workflow source. A named organization's workflow supported by a reviewed primary source. Stage is reported separately; this label does not establish measured outcomes or independent validation.
Last researched Oct 26, 2026. Source access and reported stage are recorded below; deployment evidence does not establish ROI.
What the research supports
Machine learning combines protocol, historical recruitment and real-world data to help study teams select trial sites.
- Reported stage
- Production
- Technology
- Machine Learning
- Business function
- Middle Office
- Impact (legacy label)
- Not labeled
- Catalog date · unconfirmed
- Not reported
- Imported
- Oct 29, 2026
- Last researched
- Oct 26, 2026
Measures & evidence
No quantified measure recorded. This is a gap in the evidence, not a finding of no value.
Documented vendor relationships
No vendor relationship has been linked to this specific workflow in the curated overlay. This does not mean it was built without vendors.
See the company’s documented relationshipsDeployment evidence & limits
Issuer describes actual ATOMIC/CfOR site-location work for an Lp(a) trial and human team use of scorecards. Status date not established.
Stage is as reported in the cited evidence. Current operating status has not been independently reconfirmed; the research date is an editorial review date.
Article is dated April 2025 by URL, with exact day not recorded; no causal recruitment uplift or FS uplift asserted. Clinical eligibility and financial eligibility differ. Prevent historical exclusion from becoming a targeting rule and measure calibration by segment.
Potential FS application · inferred
Inferred: Select branches or advisers for a new-service pilot by forecasting participation and operational readiness while monitoring representation.
Predictive ranking combines local demand, historical throughput and constraints to allocate rollout resources.
Original industry: Pharmaceuticals and biotechnology. Transfer limits: Clinical eligibility and financial eligibility differ. Prevent historical exclusion from becoming a targeting rule and measure calibration by segment.
Recorded dependencies
- Traceable source data and approved document/control schemas
- Qualified human review and local testing of accuracy, omissions and full workflow effort
Source register
- Follow the Dataamgen.com · opens in a new tab
Amgen · issuer · full-text · Publication date not recorded
Research lanes: health_life_sciences · Batch global-discovery-2026-10-26. Coverage and remaining gaps